Agile Therapeutics Ownership 2024 | Who Owns Agile Therapeutics Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

0.00%

Insider Ownership

9.70%

Retail Ownership

90.30%

Institutional Holders

1.00

Agile Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-10	-100.00%	-	Mar 31, 2024

Agile Therapeutics's largest institutional shareholder is CORNERSTONE PLANNING GROUP LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-10	-100.00%	-	Mar 31, 2024

The largest Agile Therapeutics shareholder by % of total assets is CORNERSTONE PLANNING GROUP LLC. The company owns 0.00 shares of Agile Therapeutics (AGRX), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-10	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Agile Therapeutics's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased -10.00 stocks of AGRX, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-10	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Agile Therapeutics's biggest institutional seller is CORNERSTONE PLANNING GROUP LLC. The company sold -10.00 shares of AGRX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CORNERSTONE PLANNING GROUP LLC	-	-	-	-10	-100.00%	-	Mar 31, 2024

Agile Therapeutics's largest sold out institutional shareholder by shares sold is CORNERSTONE PLANNING GROUP LLC, sold -10.00 shares, valued at -, as of undefined.

Agile Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
ROYCE MICRO-CAP TRUST, INC.	0.19%	90,000	-	-	Mar 31, 2024
NEEDHAM FUNDS INC	0.17%	350,000	-	-	Mar 31, 2024
JOHN HANCOCK INVESTMENT TRUST	0.02%	1,815,895	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.02%	12,045	-	-	Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.02%	114,870	-	-	Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS	0.02%	73,421	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.01%	3,755,385	-	-	Mar 31, 2024
NEXPOINT FUNDS I	0.01%	25,000	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	630,921	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	70,357	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	5,999	-	-	Mar 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	40,600	-	-	Feb 29, 2024
Principal Exchange-Traded Funds	0.00%	17,409	-	-	Mar 31, 2024
RBB FUND, INC.	0.00%	126,000	-	-	Feb 29, 2024
TIAA-CREF LIFE FUNDS	0.00%	3,534	-	-	Mar 31, 2024
FLEXSHARES TRUST	0.00%	101,904	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	237,651	-	-	Feb 29, 2024
SunAmerica Specialty Series	0.00%	560	-	-	Apr 30, 2021
Voya VARIABLE PORTFOLIOS INC	0.00%	32,073	-	-	Mar 31, 2024
GPS Funds I	0.00%	4,563	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	31,320	-	-	Feb 29, 2024
THRIVENT SERIES FUND INC	0.00%	54,404	-	-	Mar 28, 2024
NORTHERN FUNDS	0.00%	38,788	-	-	Mar 28, 2024
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	2,623	-	-	Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	12,200	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.00%	76,860	-	-	Mar 31, 2024
THRIVENT MUTUAL FUNDS	0.00%	14,740	-	-	Mar 28, 2024
PGIM ETF TRUST	0.00%	8,549	-	-	Feb 29, 2024
ProFunds	0.00%	1,474	-	-	Mar 31, 2024
FIDELITY SALEM STREET TRUST	0.00%	489,308	-	-	Mar 31, 2024
VALIC Co I	0.00%	32,235	-	-	Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	220,972	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	40,954	-	-	Mar 31, 2024
PENN SERIES FUNDS INC	0.00%	2,700	-	-	Mar 28, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	11,745	-	-	Mar 31, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	10,243	-	-	Jan 31, 2024
Goldman Sachs ETF Trust	0.00%	7,440	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	15,531	1,752	12.72%	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	14,055	-	-	Jan 31, 2024
TIAA-CREF FUNDS	0.00%	179,791	-	-	Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	53,814	-	-	Mar 31, 2024
VANGUARD WELLINGTON FUND	0.00%	17,989	-	-	Feb 29, 2024
NEEDHAM FUNDS INC	0.00%	88	-4,661	-98.15%	Mar 31, 2024
NEEDHAM FUNDS INC	0.00%	88	-	-	Mar 31, 2024
Brighthouse Funds Trust II	0.00%	33,678	-	-	Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	3,643	-	-	Feb 29, 2024
Tidal Trust II	0.00%	762	-	-	Jan 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	58,600	-	-	Mar 31, 2024
SUNAMERICA SERIES TRUST	0.00%	7,345	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	245,923	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	14,492	-	-	Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS	0.00%	48	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	35,200	-	-	Mar 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	8,266	-	-	Dec 31, 2023
Bridge Builder Trust	0.00%	26,495	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	1,832	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	5,254	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	14,219	-	-	Feb 29, 2024
BlackRock Variable Series Funds, Inc.	0.00%	8,972	-	-	Mar 31, 2024
BLACKROCK FUNDS	0.00%	8,092	-	-	Mar 28, 2024
iSHARES TRUST	0.00%	14,748	-	-	Mar 31, 2024
John Hancock Funds II	0.00%	11,529	-	-	Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	16,200	-	-	Feb 29, 2024
Advisors' Inner Circle Fund III	0.00%	46	-	-	Jan 31, 2024

Agile Therapeutics's largest mutual fund holder by % of total assets is "ROYCE MICRO-CAP TRUST, INC.", owning 90.00K shares, compromising 0.19% of its total assets.

Agile Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Dec, 23	1	-
31 Mar, 22	35	-25.53%
31 Dec, 21	47	-12.96%
30 Sep, 21	54	-25.00%
30 Jun, 21	72	-10.00%
31 Mar, 21	80	-5.88%
31 Dec, 20	85	-1.16%
30 Sep, 20	86	1.18%
30 Jun, 20	85	21.43%
31 Mar, 20	70	32.08%
31 Dec, 19	53	55.88%
30 Sep, 19	34	25.93%
30 Jun, 19	27	-3.57%
31 Mar, 19	28	3.70%
31 Dec, 18	27	-3.57%
30 Sep, 18	28	-26.32%
30 Jun, 18	38	-20.83%
31 Mar, 18	48	-7.69%
31 Dec, 17	52	6.12%
30 Sep, 17	49	8.89%
30 Jun, 17	45	-13.46%
31 Mar, 17	52	-21.21%
31 Dec, 16	66	13.79%
30 Sep, 16	58	1.75%
30 Jun, 16	57	7.55%
31 Mar, 16	53	8.16%
31 Dec, 15	49	-
30 Sep, 15	49	-14.04%
30 Jun, 15	57	46.15%
31 Mar, 15	39	77.27%
31 Dec, 14	22	-4.35%
30 Sep, 14	23	15.00%
30 Jun, 14	20	-

As of 31 Dec 23, 1 institutions are holding Agile Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Dec, 23	10	-
31 Mar, 22	40,559,779	7.73%
31 Dec, 21	37,651,153	18.45%
30 Sep, 21	31,787,149	-7.56%
30 Jun, 21	34,385,876	-10.17%
31 Mar, 21	38,279,166	-5.42%
31 Dec, 20	40,473,649	4.16%
30 Sep, 20	38,855,790	0.98%
30 Jun, 20	38,478,555	16.51%
31 Mar, 20	33,025,635	21.30%
31 Dec, 19	27,226,133	13.28%
30 Sep, 19	24,033,991	22.75%
30 Jun, 19	19,579,798	5.62%
31 Mar, 19	18,538,164	96.54%
31 Dec, 18	9,432,299	-34.68%
30 Sep, 18	14,440,164	-19.21%
30 Jun, 18	17,872,674	-27.60%
31 Mar, 18	24,685,305	1.42%
31 Dec, 17	24,338,567	-2.35%
30 Sep, 17	24,925,236	8.02%
30 Jun, 17	23,075,553	0.52%
31 Mar, 17	22,957,028	-1.96%
31 Dec, 16	23,414,959	-2.47%
30 Sep, 16	24,007,669	-0.75%
30 Jun, 16	24,188,418	-0.81%
31 Mar, 16	24,385,433	47.39%
31 Dec, 15	16,544,352	-22.79%
30 Sep, 15	21,428,616	24.98%
30 Jun, 15	17,145,049	3.51%
31 Mar, 15	16,563,019	27.00%
31 Dec, 14	13,041,523	68.86%
30 Sep, 14	7,723,423	-4.03%
30 Jun, 14	8,047,341	-

Agile Therapeutics (AGRX) has 10.00 shares outstanding as of 31 Dec 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Dec, 23	0.00%	-
31 Mar, 22	32.55%	2.16%
31 Dec, 21	38.79%	3.62%
30 Sep, 21	32.75%	1.99%
30 Jun, 21	40.61%	1.99%
31 Mar, 21	45.20%	1.98%
31 Dec, 20	47.79%	2.27%
30 Sep, 20	45.88%	0.76%
30 Jun, 20	77.84%	1.74%
31 Mar, 20	66.81%	2.20%
31 Dec, 19	55.08%	2.33%
30 Sep, 19	48.62%	3.10%
30 Jun, 19	39.61%	2.82%
31 Mar, 19	37.50%	10.30%
31 Dec, 18	19.08%	2.24%
30 Sep, 18	29.21%	2.23%
30 Jun, 18	36.16%	1.45%
31 Mar, 18	49.94%	2.06%
31 Dec, 17	49.24%	1.94%
30 Sep, 17	50.42%	2.31%
30 Jun, 17	46.68%	2.16%
31 Mar, 17	46.44%	2.07%
31 Dec, 16	47.37%	2.01%
30 Sep, 16	48.57%	2.03%
30 Jun, 16	48.93%	2.01%
31 Mar, 16	49.33%	4.40%
31 Dec, 15	33.47%	1.78%
30 Sep, 15	43.35%	3.60%
30 Jun, 15	34.68%	3.09%
31 Mar, 15	33.51%	4.81%
31 Dec, 14	26.38%	10.81%
30 Sep, 14	15.62%	5.90%
30 Jun, 14	16.28%	-

As of 31 Dec 23, Agile Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Dec, 23	1	-
31 Mar, 22	16	-27.27%
31 Dec, 21	22	69.23%
30 Sep, 21	13	-60.61%
30 Jun, 21	33	-
31 Mar, 21	33	-13.16%
31 Dec, 20	38	11.76%
30 Sep, 20	34	-44.26%
30 Jun, 20	61	24.49%
31 Mar, 20	49	25.64%
31 Dec, 19	39	95.00%
30 Sep, 19	20	122.22%
30 Jun, 19	9	-30.77%
31 Mar, 19	13	30.00%
31 Dec, 18	10	-16.67%
30 Sep, 18	12	-25.00%
30 Jun, 18	16	-11.11%
31 Mar, 18	18	-45.45%
31 Dec, 17	33	32.00%
30 Sep, 17	25	25.00%
30 Jun, 17	20	-25.93%
31 Mar, 17	27	-18.18%
31 Dec, 16	33	37.50%
30 Sep, 16	24	-20.00%
30 Jun, 16	30	-9.09%
31 Mar, 16	33	73.68%
31 Dec, 15	19	-9.52%
30 Sep, 15	21	-44.74%
30 Jun, 15	38	22.58%
31 Mar, 15	31	181.82%
31 Dec, 14	11	-15.38%
30 Sep, 14	13	-35.00%
30 Jun, 14	20	-

1 institutional shareholders have increased their position in AGRX stock as of 31 Dec 23 compared to 16 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Dec, 23	-	-
31 Mar, 22	7	-46.15%
31 Dec, 21	13	-40.91%
30 Sep, 21	22	-12.00%
30 Jun, 21	25	-
31 Mar, 21	25	38.89%
31 Dec, 20	18	-41.94%
30 Sep, 20	31	244.44%
30 Jun, 20	9	-10.00%
31 Mar, 20	10	66.67%
31 Dec, 19	6	20.00%
30 Sep, 19	5	66.67%
30 Jun, 19	3	-57.14%
31 Mar, 19	7	-
31 Dec, 18	7	16.67%
30 Sep, 18	6	-33.33%
30 Jun, 18	9	-47.06%
31 Mar, 18	17	88.89%
31 Dec, 17	9	-10.00%
30 Sep, 17	10	-37.50%
30 Jun, 17	16	45.45%
31 Mar, 17	11	-26.67%
31 Dec, 16	15	7.14%
30 Sep, 16	14	-12.50%
30 Jun, 16	16	77.78%
31 Mar, 16	9	-35.71%
31 Dec, 15	14	7.69%
30 Sep, 15	13	18.18%
30 Jun, 15	11	266.67%
31 Mar, 15	3	-25.00%
31 Dec, 14	4	-33.33%
30 Sep, 14	6	-
30 Jun, 14	-	-

- institutional shareholders have reduced their position in AGRX stock as of 31 Dec 23 compared to 7 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Dec, 23	1	-	10	-	0.00%	-	1	-	-	-
31 Mar, 22	35	-25.53%	40,559,779	7.73%	32.55%	2.16%	16	-27.27%	7	-46.15%
31 Dec, 21	47	-12.96%	37,651,153	18.45%	38.79%	3.62%	22	69.23%	13	-40.91%
30 Sep, 21	54	-25.00%	31,787,149	-7.56%	32.75%	1.99%	13	-60.61%	22	-12.00%
30 Jun, 21	72	-10.00%	34,385,876	-10.17%	40.61%	1.99%	33	-	25	-
31 Mar, 21	80	-5.88%	38,279,166	-5.42%	45.20%	1.98%	33	-13.16%	25	38.89%
31 Dec, 20	85	-1.16%	40,473,649	4.16%	47.79%	2.27%	38	11.76%	18	-41.94%
30 Sep, 20	86	1.18%	38,855,790	0.98%	45.88%	0.76%	34	-44.26%	31	244.44%
30 Jun, 20	85	21.43%	38,478,555	16.51%	77.84%	1.74%	61	24.49%	9	-10.00%
31 Mar, 20	70	32.08%	33,025,635	21.30%	66.81%	2.20%	49	25.64%	10	66.67%
31 Dec, 19	53	55.88%	27,226,133	13.28%	55.08%	2.33%	39	95.00%	6	20.00%
30 Sep, 19	34	25.93%	24,033,991	22.75%	48.62%	3.10%	20	122.22%	5	66.67%
30 Jun, 19	27	-3.57%	19,579,798	5.62%	39.61%	2.82%	9	-30.77%	3	-57.14%
31 Mar, 19	28	3.70%	18,538,164	96.54%	37.50%	10.30%	13	30.00%	7	-
31 Dec, 18	27	-3.57%	9,432,299	-34.68%	19.08%	2.24%	10	-16.67%	7	16.67%
30 Sep, 18	28	-26.32%	14,440,164	-19.21%	29.21%	2.23%	12	-25.00%	6	-33.33%
30 Jun, 18	38	-20.83%	17,872,674	-27.60%	36.16%	1.45%	16	-11.11%	9	-47.06%
31 Mar, 18	48	-7.69%	24,685,305	1.42%	49.94%	2.06%	18	-45.45%	17	88.89%
31 Dec, 17	52	6.12%	24,338,567	-2.35%	49.24%	1.94%	33	32.00%	9	-10.00%
30 Sep, 17	49	8.89%	24,925,236	8.02%	50.42%	2.31%	25	25.00%	10	-37.50%
30 Jun, 17	45	-13.46%	23,075,553	0.52%	46.68%	2.16%	20	-25.93%	16	45.45%
31 Mar, 17	52	-21.21%	22,957,028	-1.96%	46.44%	2.07%	27	-18.18%	11	-26.67%
31 Dec, 16	66	13.79%	23,414,959	-2.47%	47.37%	2.01%	33	37.50%	15	7.14%
30 Sep, 16	58	1.75%	24,007,669	-0.75%	48.57%	2.03%	24	-20.00%	14	-12.50%
30 Jun, 16	57	7.55%	24,188,418	-0.81%	48.93%	2.01%	30	-9.09%	16	77.78%
31 Mar, 16	53	8.16%	24,385,433	47.39%	49.33%	4.40%	33	73.68%	9	-35.71%
31 Dec, 15	49	-	16,544,352	-22.79%	33.47%	1.78%	19	-9.52%	14	7.69%
30 Sep, 15	49	-14.04%	21,428,616	24.98%	43.35%	3.60%	21	-44.74%	13	18.18%
30 Jun, 15	57	46.15%	17,145,049	3.51%	34.68%	3.09%	38	22.58%	11	266.67%
31 Mar, 15	39	77.27%	16,563,019	27.00%	33.51%	4.81%	31	181.82%	3	-25.00%
31 Dec, 14	22	-4.35%	13,041,523	68.86%	26.38%	10.81%	11	-15.38%	4	-33.33%
30 Sep, 14	23	15.00%	7,723,423	-4.03%	15.62%	5.90%	13	-35.00%	6	-
30 Jun, 14	20	-	8,047,341	-	16.28%	-	20	-	-	-

Agile Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Aug 25, 2023	Coiante Scott M	officer	Chief Financial Officer		Sell	-	-	-	80

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Oct 04, 2023	Coiante Scott M	officer	Chief Financial Officer	A-Award	Buy	20,000	-	-	20,080
Aug 25, 2023	Coiante Scott M	officer	Chief Financial Officer		Sell	-	-	-	80
Jun 30, 2023	Welsh Amy	officer	Chief Commercial Officer	A-Award	Buy	13,500	-	-	13,500
Jun 30, 2023	Welsh Amy	officer	Chief Commercial Officer	A-Award	Buy	4,500	$2.48	$11.16K	4,500
Jun 30, 2023	Korner Paul	officer	Chief Medical Officer	A-Award	Buy	13,500	-	-	13,500
Jun 30, 2023	Korner Paul	officer	Chief Medical Officer	A-Award	Buy	4,500	$2.48	$11.16K	4,500
Jun 30, 2023	ALTOMARI ALFRED	director, officer	Chief Executive Officer	A-Award	Buy	8,963	-	-	47,749
Jun 30, 2023	ALTOMARI ALFRED	director, officer	Chief Executive Officer	A-Award	Buy	37,500	-	-	38,786
Jun 30, 2023	ALTOMARI ALFRED	director, officer	Chief Executive Officer	A-Award	Buy	12,500	$2.48	$31.00K	12,500
Jun 30, 2023	Conway Robert G	officer	Chief Supply Chain Officer	A-Award	Buy	13,500	-	-	13,529
Jun 30, 2023	Conway Robert G	officer	Chief Supply Chain Officer	A-Award	Buy	4,500	$2.48	$11.16K	4,500
Jun 30, 2023	Gilmore Geoffrey	officer	Chief Administrative Officer	A-Award	Buy	6,716	-	-	20,256
Jun 30, 2023	Gilmore Geoffrey	officer	Chief Administrative Officer	A-Award	Buy	13,500	-	-	13,540
Jun 30, 2023	Gilmore Geoffrey	officer	Chief Administrative Officer	A-Award	Buy	4,500	$2.48	$11.16K	4,500
Jun 09, 2023	Torrente Josephine	director	-	A-Award	Buy	1,065	$3.58	$3.81K	1,065
Jun 09, 2023	Torrente Josephine	director	-	A-Award	Buy	935	-	-	988
Jun 09, 2023	Fischer Seth H. Z.	director	-	A-Award	Buy	1,065	$3.58	$3.81K	1,065
Jun 09, 2023	Fischer Seth H. Z.	director	-	A-Award	Buy	935	-	-	976
Jun 09, 2023	Hubbard John W	director	-	A-Award	Buy	1,065	$3.58	$3.81K	1,065
Jun 09, 2023	Hubbard John W	director	-	A-Award	Buy	935	-	-	976

The last insider sell of Agile Therapeutics's stock was made by Coiante Scott M on Aug 25 2023, selling - shares at - per share (valued at -).

Agile Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	1	-	-
Q3 2023	-	1	-
Q2 2023	22	-	-
Q4 2022	6	1	600.00%
Q3 2022	1	-	-
Q2 2022	7	-	-
Q1 2022	6	-	-
Q4 2021	8	-	-
Q3 2021	2	-	-
Q2 2021	14	-	-
Q1 2021	12	2	600.00%
Q4 2020	1	1	100.00%
Q3 2020	4	2	200.00%
Q2 2020	13	1	1300.00%
Q1 2020	17	1	1700.00%
Q4 2019	4	2	200.00%
Q3 2019	4	-	-
Q2 2019	7	-	-
Q1 2019	21	9	233.33%
Q3 2018	-	1	-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Agile Therapeutics's insiders, as of Q4 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	1	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	6	-	-
Q3 2021	2	-	-
Q2 2021	2	-	-
Q1 2021	4	-	-
Q4 2020	-	-	-
Q3 2020	1	-	-
Q2 2020	-	-	-
Q1 2020	5	-	-
Q4 2019	4	2	200.00%
Q3 2019	1	-	-
Q2 2019	1	-	-
Q1 2019	3	-	-
Q3 2018	-	1	-

As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Agile Therapeutics's stocks.

Agile Therapeutics Peer Ownership

Ticker	Company
EVOK	Evoke Pharma, Inc.
TKNO	Alpha Teknova, Inc.
AMRX	Amneal Pharmaceuticals, Inc.
AQST	Aquestive Therapeutics, Inc.
LFCR	Lifecore Biomedical, Inc.
GHSI	Guardion Health Sciences, Inc.
ASRT	Assertio Holdings, Inc.
SHPH	Shuttle Pharmaceuticals Holdings, Inc.
PTPI	Petros Pharmaceuticals, Inc.
ACRX	Talphera, Inc.
CPIX	Cumberland Pharmaceuticals Inc.
CYTH	Cyclo Therapeutics, Inc.
PRFX	PainReform Ltd.

AGRX Ownership FAQ

Who Owns Agile Therapeutics?

Agile Therapeutics is owned by institutional shareholders (0.00%), insiders (9.70%), and public (90.30%). The largest institutional shareholder of Agile Therapeutics is CORNERSTONE PLANNING GROUP LLC (0% of total shares) and the top mutual fund owner is ROYCE MICRO-CAP TRUST, INC. (0.19% of total shares).

Who are the major institutional shareholders of Agile Therapeutics?

Agile Therapeutics's major institutional shareholders are CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0% of the company's share outstanding.

How many Agile Therapeutics shareholders are there?

As of Dec 2023, there are 1 institutional shareholders of Agile Therapeutics.

What percentage of Agile Therapeutics is owned by CORNERSTONE PLANNING GROUP LLC?

CORNERSTONE PLANNING GROUP LLC owns 0 shares of Agile Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).